PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $511,000 | +126.1% | 162,336 | +108.9% | 1.19% | +162.3% |
| Q2 2020 | $226,000 | +4.1% | 77,707 | +1.2% | 0.45% | -1.7% |
| Q1 2020 | $217,000 | -16.5% | 76,788 | -4.1% | 0.46% | -10.5% |
| Q4 2019 | $260,000 | +47.7% | 80,063 | -2.0% | 0.52% | +33.4% |
| Q3 2019 | $176,000 | -34.3% | 81,713 | -4.3% | 0.39% | -41.0% |
| Q2 2019 | $268,000 | -15.7% | 85,368 | 0.0% | 0.65% | +6.2% |
| Q1 2019 | $318,000 | +31.4% | 85,368 | +2.4% | 0.62% | +25.5% |
| Q4 2018 | $242,000 | -1.6% | 83,359 | -11.0% | 0.49% | +16.4% |
| Q3 2018 | $246,000 | +26.2% | 93,708 | +12.4% | 0.42% | +33.5% |
| Q2 2018 | $195,000 | -17.7% | 83,369 | +3.3% | 0.32% | -13.7% |
| Q1 2018 | $237,000 | +8.2% | 80,722 | +1.0% | 0.37% | -0.5% |
| Q4 2017 | $219,000 | – | 79,937 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |